Cormorant Asset Management, LP Protara Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.68 - $16.99 $3.04 Million - $5.95 Million	-350,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.97 - $25.34 $1.7 Million - $2.53 Million	-100,000 Reduced 22.22%	350,000 $8.47 Million
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $7.54 Million - $14.4 Million	450,000 New	450,000 $7.57 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $25.8M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.